JDSRX
Price
$19.27
Change
-$1.54 (-7.40%)
Updated
Apr 3 closing price
Net Assets
1.39B
VISVX
Price
$42.44
Change
-$3.06 (-6.73%)
Updated
Apr 3 closing price
Net Assets
57.63B
Ad is loading...

JDSRX vs VISVX

Header iconJDSRX vs VISVX Comparison
Open Charts JDSRX vs VISVXBanner chart's image
Janus Henderson Small Cap Value R
Price$19.27
Change-$1.54 (-7.40%)
VolumeN/A
Net Assets1.39B
Vanguard Small Cap Value Index I
Price$42.44
Change-$3.06 (-6.73%)
VolumeN/A
Net Assets57.63B
JDSRX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDSRX vs. VISVX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDSRX is a Buy and VISVX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. JDSRX (1.39B). VISVX pays higher dividends than JDSRX: VISVX (2.14) vs JDSRX (1.12). JDSRX was incepted earlier than VISVX: JDSRX (16 years) vs VISVX (27 years). JDSRX (1.69) is less costly to investors than VISVX (0.19). JDSRX is a more actively managed with annual turnover of: 36.00 vs. VISVX (16.00). JDSRX has a lower initial minimum investment than VISVX: JDSRX (2500) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 1.29 vs. JDSRX (-12.07). VISVX return over 5 years is better than : 137.90 vs. JDSRX (49.13).
JDSRXVISVXJDSRX / VISVX
Total Expense Ratio1.690.19889%
Annual Report Gross Expense Ratio1.690.19889%
Fund Existence16 years27 years-
Gain YTD-4.672-4.142113%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B57.6B2%
Annual Yield % from dividends1.122.1452%
Returns for 1 year-12.071.29-935%
Returns for 3 years-10.539.10-116%
Returns for 5 years49.13137.9036%
Returns for 10 years-3.3179.80-4%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POAI1.37-0.03
-2.14%
Predictive Oncology
RDCM11.20-0.40
-3.45%
Radcom Ltd
XERS4.88-0.27
-5.24%
Xeris Biopharma Holdings
RPD25.58-1.86
-6.78%
Rapid7
CFG36.22-5.44
-13.06%
Citizens Financial Group